Decision-tree model for health economic comparison of two long-acting somatostatin receptor ligand devices in France, Germany, and the UK

Overview of attention for article published in Medical Devices : Evidence and Research, May 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)

Mentioned by

policy: 2 policy sources

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 20 Mendeley

Summary Policy documents Dimensions citations

So far, Dimensions has found 17 publications that cite this research output.

17

The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.

COMPARATIVE PHARMACOECONOMIC ANALYSIS OF LONG-ACTING LANREOTIDE USED IN ACROMEGALY THERAPY WITHIN CONDITIONS OF THE RUSSIAN FEDERATION HEALTH CARE SYSTEM

Article in Pharmacy & Pharmacology (May 2022)

Evaluating cost-effectiveness in the management of neuroendocrine neoplasms

Article in Reviews in Endocrine and Metabolic Disorders (November 2020)

French Patient-Reported Experience of Diagnosis, Management and Burden of Neuroendocrine Tumors

Article in International Journal of Endocrine Oncology (June 2020)